We have previously reported that gefitinib inhibits the spontaneous intrahepatic metastasis of hepatocellular carcinoma by blocking the EGFR-mediated metastatic properties (Matsuo et al, 2003). Here, EGFR is linked to hepatocellular carcinoma.